Back to results
US 2018/0008704 A1Published application
Cd200 inhibitors and methods of use thereof
AssigneeRegents of the University of Minnesota
InventorMichael Olin
Life of this patent
Estimating the term…
Abstract
The present invention provides in certain embodiments conjugates comprising at least one CD200 inhibitor and an adjuvant, and methods of reversing or modulating immune suppression in a patient having a disease or disorder arising from abnormal cell growth, function or behavior, which method comprises administering to a patient in need thereof a composition comprising a CD200 inhibitor and an adjuvant.
Claims20
A conjugate comprising at least one CD200 inhibitor operably linked to an adjuvant.
Dependencies are inferred from the claim text.